美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Opthea Limited

0.4400

+0.0000

成交量：- -

成交額：- -

市值：5.42億

市盈率：-1.67

高：0.4400

開：0.4400

低：0.4400

收：0.4400

資料載入中...

總覽公司新聞公告

Opthea Limited盤中異動股價大漲8.64%

Opthea Limited盤中異動股價大跌5.47%

Opthea Limited盤中異動早盤股價大跌7.54%報3.68美元

Opthea Limited盤中異動急速拉昇12.96%

Opthea Limited盤中異動急速下跌6.85%報4.76美元

Opthea Limited盤中異動早盤大幅上漲6.70%報4.78美元

Opthea Limited盤中異動股價大跌5.00%

Opthea Limited盤中異動早盤股價大漲7.14%報4.95美元

Opthea Limited盤中異動股價大漲5.48%報5.26美元

Opthea Limited盤中異動早盤大幅拉昇5.65%

Opthea Limited盤中異動股價大跌5.17%

Opthea Limited盤中異動股價大漲5.81%報5.46美元

Opthea Limited盤中異動股價大跌5.40%報5.24美元

Opthea Limited盤中異動股價大跌6.11%報5.38美元

Opthea Limited盤中異動大幅拉昇5.08%

Opthea Limited盤中異動早盤大幅拉昇5.75%

Opthea Limited盤中異動股價大跌9.53%

Opthea Limited盤中異動股價大漲6.31%

Opthea Limited盤中異動下午盤股價大漲6.07%報5.38美元

Opthea Limited盤中異動快速拉昇5.66%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CKDXF/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CKDXF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CKDXF\",,,,,undefined,":{"symbol":"CKDXF","market":"US","secType":"STK","nameCN":"Opthea Limited","latestPrice":0.44,"timestamp":1744315200000,"preClose":0.44,"halted":0,"volume":0,"delay":15,"floatShares":773174816,"shares":1231094617,"eps":-0.263143,"marketStatus":"盤前交易","change":0,"latestTime":"04-10 16:00:00 EDT 延時","open":0.44,"high":0.44,"low":0.44,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.263143,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1744378200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.44,"volumeRatio":0.7068399161573908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CKDXF\",,,,,undefined,":{"symbol":"CKDXF","floatShares":773174816,"roa":"-73.34%","roe":"-3383.08%","lyrEps":-0.345097,"volumeRatio":0.7068399161573908,"shares":1231094617,"dividePrice":0,"high":0.44,"amplitude":0,"preClose":0.44,"low":0.44,"week52Low":0.44,"pbRate":"-3.21","psRate":"2593.53","week52High":0.57,"institutionHeld":0,"latestPrice":0.44,"eps":-0.263143,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.263143,"open":0.44,"prevYearClose":0.44,"prevWeekClose":0.44,"prevMonthClose":0.44,"prevQuarterClose":0.44,"fiveDayClose":0.44,"twentyDayClose":0.44,"sixtyDayClose":0.44},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CKDXF\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518744402","title":"Opthea Limited盤中異動 股價大漲8.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518744402?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 21:33","pubTimestamp":1741700007,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日21时33分，Opthea Limited股票出现异动，股价大幅拉升8.64%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.84%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031121332796416576&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031121332796416576&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2518275591","title":"Opthea Limited盤中異動 股價大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518275591?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 21:31","pubTimestamp":1741613487,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Opthea Limited股票出现波动，股价大幅跳水5.47%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1808.81%、383.42%、45.40%，振幅较大的相关个股有Xencor, Inc.、Y-Mabs Therapeutics, Inc.、Aditxt, Inc.，振幅分别为99.13%、94.67%、10.29%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213127abf2fbce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213127abf2fbce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2517166023","title":"Opthea Limited盤中異動 早盤股價大跌7.54%報3.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517166023?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:36","pubTimestamp":1741271815,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时36分，Opthea Limited股票出现波动，股价快速跳水7.54%。截至发稿，该股报3.68美元/股，成交量1256股，换手率0.00%，振幅6.38%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.52%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223655989eb589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223655989eb589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2517946983","title":"Opthea Limited盤中異動 急速拉昇12.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517946983?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:31","pubTimestamp":1741185080,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Opthea Limited股票出现异动，股价急速上涨12.96%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.08%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223120a260c719&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223120a260c719&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2516779066","title":"Opthea Limited盤中異動 急速下跌6.85%報4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516779066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516779066?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:34","pubTimestamp":1741098861,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时34分，Opthea Limited股票出现波动，股价快速下跌6.85%。截至发稿，该股报4.76美元/股，成交量5103股，换手率0.00%，振幅8.02%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.08%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223421a25f058f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223421a25f058f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2516637590","title":"Opthea Limited盤中異動 早盤大幅上漲6.70%報4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516637590?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:01","pubTimestamp":1741014084,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时01分，Opthea Limited股票出现波动，股价急速拉升6.70%。截至发稿，该股报4.78美元/股，成交量998股，换手率0.00%，振幅7.14%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.05%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032301249637b4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032301249637b4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2516301505","title":"Opthea Limited盤中異動 股價大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516301505?lang=zh_tw&edition=fundamental","pubTime":"2025-03-01 04:54","pubTimestamp":1740776069,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时54分，Opthea Limited股票出现波动，股价急速下挫5.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.77%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454309634672b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454309634672b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2514890523","title":"Opthea Limited盤中異動 早盤股價大漲7.14%報4.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514890523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514890523?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:07","pubTimestamp":1740668843,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时07分，Opthea Limited股票出现异动，股价急速拉升7.14%。截至发稿，该股报4.95美元/股，成交量2673股，换手率0.00%，振幅9.96%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.83%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272307239632b91e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272307239632b91e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2513296624","title":"Opthea Limited盤中異動 股價大漲5.48%報5.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513296624?lang=zh_tw&edition=fundamental","pubTime":"2025-02-21 22:44","pubTimestamp":1740149093,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时44分，Opthea Limited股票出现异动，股价大幅拉升5.48%。截至发稿，该股报5.26美元/股，成交量1121股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.42%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224453988de171&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224453988de171&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2512483317","title":"Opthea Limited盤中異動 早盤大幅拉昇5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512483317?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 22:31","pubTimestamp":1739975474,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Opthea Limited股票出现异动，股价快速拉升5.65%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Cellectar Biosciences, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为202.21%、201.40%、65.46%，振幅较大的相关个股有Allogene Therapeutics, Inc.、Azitra Inc、Cellectar Biosciences, Inc.，振幅分别为16.90%、11.29%、6.05%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223114abd4fdf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223114abd4fdf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2512016782","title":"Opthea Limited盤中異動 股價大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512016782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512016782?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 00:25","pubTimestamp":1739895926,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时25分，Opthea Limited股票出现波动，股价大幅跳水5.17%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.64%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190025279627ab5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190025279627ab5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2511696764","title":"Opthea Limited盤中異動 股價大漲5.81%報5.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511696764?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 22:32","pubTimestamp":1739543533,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Opthea Limited股票出现异动，股价大幅上涨5.81%。截至发稿，该股报5.46美元/股，成交量2859股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.24%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321396231b7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321396231b7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2510333036","title":"Opthea Limited盤中異動 股價大跌5.40%報5.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510333036?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 23:26","pubTimestamp":1739287597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时26分，Opthea Limited股票出现异动，股价大幅下挫5.40%。截至发稿，该股报5.24美元/股，成交量3.0715万股，换手率0.02%，振幅5.33%。Opthea Limited股票所在的生物技术行业中，整体跌幅为1.61%。其相关个股中，Ocean Biomedical, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2617.43%、948.34%、356.16%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232638a2420771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232638a2420771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2510863061","title":"Opthea Limited盤中異動 股價大跌6.11%報5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510863061?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 22:31","pubTimestamp":1739197900,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Opthea Limited股票出现异动，股价快速跳水6.11%。截至发稿，该股报5.38美元/股，成交量4868股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.38%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223140a240a1da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223140a240a1da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2509277707","title":"Opthea Limited盤中異動 大幅拉昇5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509277707?lang=zh_tw&edition=fundamental","pubTime":"2025-02-06 23:01","pubTimestamp":1738854098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时01分，Opthea Limited股票出现异动，股价快速上涨5.08%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.01%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206230138987c941c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206230138987c941c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2509282607","title":"Opthea Limited盤中異動 早盤大幅拉昇5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509282607?lang=zh_tw&edition=fundamental","pubTime":"2025-02-05 22:35","pubTimestamp":1738766155,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时35分，Opthea Limited股票出现波动，股价大幅上涨5.75%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2939.46%、752.04%、624.31%，振幅较大的相关个股有Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为34.67%、23.35%、22.22%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223555987b7c91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223555987b7c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2508142590","title":"Opthea Limited盤中異動 股價大跌9.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508142590?lang=zh_tw&edition=fundamental","pubTime":"2025-02-03 23:10","pubTimestamp":1738595413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时10分，Opthea Limited股票出现异动，股价快速跳水9.53%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.68%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231014a2381208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231014a2381208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2508814962","title":"Opthea Limited盤中異動 股價大漲6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508814962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508814962?lang=zh_tw&edition=fundamental","pubTime":"2025-01-31 23:33","pubTimestamp":1738337605,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时33分，Opthea Limited股票出现波动，股价快速拉升6.31%。Opthea Limited股票所在的生物技术行业中，整体涨幅为1.38%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312333259877671e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312333259877671e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2507723036","title":"Opthea Limited盤中異動 下午盤股價大漲6.07%報5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507723036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507723036?lang=zh_tw&edition=fundamental","pubTime":"2025-01-31 03:07","pubTimestamp":1738264071,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时07分，Opthea Limited股票出现波动，股价快速上涨6.07%。截至发稿，该股报5.38美元/股，成交量1.4397万股，换手率0.01%，振幅5.82%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.37%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013103075196145b88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013103075196145b88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2506514665","title":"Opthea Limited盤中異動 快速拉昇5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506514665?lang=zh_tw&edition=fundamental","pubTime":"2025-01-28 22:34","pubTimestamp":1738074882,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时34分，Opthea Limited股票出现波动，股价快速拉升5.66%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.07%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282234429612f4af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282234429612f4af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CKDXF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-30","symbol":"CKDXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1661832000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CKDXF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CKDXF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.1667,"hold":0.5,"sell":0.1667,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":6,"updateTime":1743566400000}}}